You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: RE43834


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE43834
Title:Injection syringe
Abstract: The present invention provides an injection syringe comprises a housing including a holder for containing a cartridge of medicine, a piston rod with a non-circular cross-section having an outer thread, a piston rod drive, a one way coupling having an annular ring of internal ratchet notches, which annular ring can be integral with the housing, and a pawl having at least a pair of resilient arms each having a free end.
Inventor(s): Steenfeldt-Jensen; Soren (Hornback, DK), Hansen; Steffen (Hillerod, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:10/442,855
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent RE43834: A Detailed Analysis of Scope and Claims

Introduction

United States Patent RE43834, titled "Injection Device," is a reissue patent that outlines a sophisticated injection mechanism designed for precise and user-friendly medication administration. This analysis will delve into the key aspects of the patent, including its scope, claims, and the broader patent landscape.

Background and Purpose

The patent RE43834 is focused on an injection device that is designed to improve the accuracy and ease of use in administering medication. This device is particularly relevant in the healthcare sector, where precise dosing and user-friendly interfaces are crucial.

Scope of the Patent

The scope of the patent encompasses a detailed description of an injection mechanism that includes several innovative features:

Key Components

  • Piston Rod and Non-Rotatable Part: The mechanism involves a piston rod that moves axially in a distal direction to expel medication, without rotating, unless an axial force is applied. This is achieved through the screwed engagement of the thread on the piston rod with the internal thread of the non-rotatable part[1].

Dose Setting and Scale Drum

  • Dose Scale Drum: The device includes a dose scale drum that is threadedly engaged with a second thread element fixed to the housing. This allows the dose scale drum to rotate and indicate the set dose size, visible through a window. The drum can be rotated to reduce a wrongly set dose without injecting medication[1].

Injection Mechanism

  • Axial Force and Rotation: When an axial force is applied to press the injection button, it transforms into rotational movement of the piston rod, causing it to advance distally and expel the medication. The tube moves axially without rotating during injection[1].

Claims of the Patent

The patent includes several claims that define the specific features and functionalities of the injection device:

Primary Claims

  • Claim 19: Describes the injection mechanism with a piston rod that advances distally to expel medication due to the screwed engagement with the non-rotatable part[1].

Dependent Claims

  • Claim 20: Adds the feature of a dose scale drum that is threadedly engaged with a second thread element, allowing rotational movement to indicate the dose size[1].
  • Claim 21: Specifies that the tube is prevented from rotating relative to the housing during injection, and the dose scale rotates to a zero position during injection[1].
  • Claim 22: Details that the dose scale drum is journalled on the tube and the tube is locked against rotations during an injection[1].

Additional Features

  • Claim 24: Includes a first button for setting a dose and a second button for receiving the force necessary to drive the medication from the cartridge[1].
  • Claim 26: Describes an injection button that receives the force necessary to drive the medication from the cartridge during injection[1].

Patent Landscape

The patent landscape surrounding RE43834 involves several key aspects:

Reissue Patents

  • Reissue patents like RE43834 are granted to correct defects in the original patent or to make changes that do not enlarge the scope of the claims. This process ensures that the patent remains valid and enforceable[4].

Patent Eligibility and Validity

  • The validity of patent claims is subject to scrutiny under 35 U.S.C. § 101 and § 112. Claims must be definite and particularly point out and distinctly claim the subject matter of the invention. The Supreme Court has established that claims directed to abstract ideas, laws of nature, and natural phenomena are not patent-eligible unless they integrate these concepts into something more[2].

Data and Research

  • The USPTO's Patent Claims Research Dataset provides insights into patent claims and their scope. This dataset can be used to analyze trends and statistics related to patent claims, including those in the medical device sector[3].

Industry Impact

The injection device described in RE43834 has significant implications for the healthcare industry:

User-Friendly Design

  • The device's design ensures that users can easily set and adjust doses without injecting medication, enhancing safety and usability[1].

Precision and Accuracy

  • The mechanism's ability to prevent the tube from rotating during injection and to indicate the dose size accurately is crucial for precise medication administration[1].

Legal and Regulatory Considerations

The patent is subject to various legal and regulatory considerations:

Terminal Disclaimers

  • The USPTO has the authority to impose conditions on terminal disclaimers, ensuring that claims are not rendered invalid if a parent patent claim is found invalid. This is consistent with statutory and case law[4].

Patent Infringement and Validity

  • Cases like Rain Gutter Pros, LLC v. MGP Manufacturing, LLC highlight the importance of patent infringement and validity disputes. These cases often involve detailed analyses of patent claims and their scope[5].

Key Takeaways

  • Innovative Mechanism: The patent describes an innovative injection mechanism with features like a non-rotating piston rod and a dose scale drum.
  • User-Friendly: The device is designed for ease of use, allowing users to set and adjust doses accurately.
  • Regulatory Compliance: The patent adheres to regulatory standards, ensuring that claims are definite and valid.
  • Industry Impact: The device has significant implications for the healthcare industry, enhancing safety and precision in medication administration.

Frequently Asked Questions (FAQs)

Q: What is the primary innovation in the injection device described in RE43834? A: The primary innovation is the mechanism that allows the piston rod to advance distally without rotating, ensuring precise medication administration.

Q: How does the dose scale drum function in this device? A: The dose scale drum is threadedly engaged with a second thread element, allowing it to rotate and indicate the set dose size, visible through a window.

Q: What is the significance of the non-rotatable part in the injection mechanism? A: The non-rotatable part ensures that the piston rod advances distally to expel medication only when an axial force is applied, preventing unwanted rotation.

Q: How does the device prevent the tube from rotating during injection? A: The tube is locked against rotations during an injection, ensuring that it moves axially without rotating.

Q: What are the implications of this patent for the healthcare industry? A: The patent has significant implications for enhancing safety, precision, and user-friendliness in medication administration.

Cited Sources

  1. Drug Patent Watch: Summary for Patent: RE43834.
  2. Court of Appeals for the Federal Circuit: Berkheimer v. HP Inc.
  3. USPTO: Patent Claims Research Dataset.
  4. Regulations.gov: Letterhead DC Office.
  5. Casetext: Rain Gutter Pros, LLC v. MGP Manufacturing, LLC.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent RE43834

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: RE43834

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark1998 00130Jan 20, 1998

International Family Members for US Patent RE43834

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2265099 ⤷  Try for Free
Australia 748277 ⤷  Try for Free
Austria 197408 ⤷  Try for Free
Brazil 9906857 ⤷  Try for Free
Canada 2305634 ⤷  Try for Free
China 1243578 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.